Does SPARSENTAN Cause Off label use? 123 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 123 reports of Off label use have been filed in association with SPARSENTAN (FILSPARI). This represents 3.8% of all adverse event reports for SPARSENTAN.
123
Reports of Off label use with SPARSENTAN
3.8%
of all SPARSENTAN reports
1
Deaths
6
Hospitalizations
How Dangerous Is Off label use From SPARSENTAN?
Of the 123 reports, 1 (0.8%) resulted in death, 6 (4.9%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SPARSENTAN. However, 123 reports have been filed with the FAERS database.
What Other Side Effects Does SPARSENTAN Cause?
Dizziness (521)
Fatigue (448)
Hypotension (377)
Product use in unapproved indication (262)
Nausea (231)
Peripheral swelling (197)
Headache (186)
Pruritus (171)
Blood creatinine increased (145)
Glomerular filtration rate decreased (141)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which SPARSENTAN Alternatives Have Lower Off label use Risk?
SPARSENTAN vs SPESOLIMAB-SBZO
SPARSENTAN vs SPIRAMYCIN
SPARSENTAN vs SPIRIVA
SPARSENTAN vs SPIRONOLACTONE
SPARSENTAN vs SPRYCEL